Table 3 Whole-body patient dosimetry results reported in organ absorbed dose difference (mean ± std) for ten patients (n = 10) and their differences to the ground truth were statistically analyzed with paired t-test.
\({\bf{M}}{\bf{e}}{\bf{a}}{\bf{n}}\,{\bf{o}}{\bf{r}}{\bf{g}}{\bf{a}}{\bf{n}}\,{\bf{a}}{\bf{b}}{\bf{s}}{\bf{o}}{\bf{r}}{\bf{b}}{\bf{e}}{\bf{d}}\,{\bf{d}}{\bf{o}}{\bf{s}}{\bf{e}}\, \% \,{\bf{d}}{\bf{i}}{\bf{f}}{\bf{f}}{\bf{e}}{\bf{r}}{\bf{e}}{\bf{n}}{\bf{c}}{\bf{e}}={{\boldsymbol{\sum }}}_{1}^{n}|\frac{{\boldsymbol{Metho}}{{\boldsymbol{d}}}_{{\boldsymbol{n}}}^{\ast }-{\boldsymbol{DM}}{{\boldsymbol{C}}}_{{\boldsymbol{n}}}^{\S }}{{\boldsymbol{DM}}{{\boldsymbol{C}}}_{{\boldsymbol{n}}}}|/{\boldsymbol{n}}\times {\bf{100}}\) | |||
|---|---|---|---|
Method | VSV | Deep-dose | Organ-based dosimetry |
Gallbladder wall | 1.12 ± 1.17 | 1.18 ± 1.20 | 22.27 ± 22.28 |
NS | NS | p < 0.001 | |
Heart wall | 2.60 ± 1.15 | 1.14 ± 1.09 | 76.39 ± 27.05 |
p < 0.05 | NS | p < 0.001 | |
Kidney | 2.55 ± 1.14 | 0.67 ± 0.57 | 3.86 ± 3.29 |
p < 0.05 | NS | p < 0.001 | |
Liver | 1.86 ± 0.71 | 1.04 ± 0.99 | 19.01 ± 31.90 |
p < 0.01 | NS | p < 0.001 | |
Lung | 53.66 ± 3.45 | 1.30 ± 1.15 | 23.43 ± 33.86 |
p < 0.001 | NS | p < 0.001 | |
Pancreas | 1.71 ± 1.09 | 1.26 ± 1.74 | 1365.72 ± 1186.49 |
NS | NS | p < 0.001 | |
Spleen | 1.55 ± 0.97 | 0.79 ± 0.77 | 46.62 ± 104.20 |
NS | NS | p < 0.001 | |
Stomach wall | 2.70 ± 1.38 | 1.35 ± 1.19 | 42.94 ± 71.27 |
p < 0.05 | NS | p < 0.001 | |
Avg. | 8.47 ± 1.38 | 1.09 ± 1.09 | 200.66 ± 185.04 |
Avg. (excluding Pancreas) | 9.43 ± 0.85 | 1.07 ± 0.22 | 34.22 ± 31.63 |
